SPDR S&P Biotech ETF
700 hedge funds and large institutions have $7.06B invested in SPDR S&P Biotech ETF in 2022 Q1 according to their latest regulatory filings, with 123 funds opening new positions, 242 increasing their positions, 186 reducing their positions, and 112 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 20 → 20 (0)
7% less capital invested
Capital invested by funds: $7.55B → $7.06B (-$497M)
7.65% less ownership
Funds ownership: 105.41% → 97.76% (-7.7%)
Holders
700
Holding in Top 10
20
Calls
$2.67B
Puts
$2.59B
Top Buyers
| 1 | +$621M | |
| 2 | +$293M | |
| 3 | +$189M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$180M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$157M |
Top Sellers
| 1 | -$408M | |
| 2 | -$219M | |
| 3 | -$214M | |
| 4 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$154M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$135M |